Bicara Therapeutics
BCAX
#7134
Rank
A$0.90 B
Marketcap
A$13.65
Share price
-2.77%
Change (1 day)
-41.65%
Change (1 year)

EPS for Bicara Therapeutics (BCAX)

EPS in 2026 (TTM): A-$4.56

According to Bicara Therapeutics's latest financial reports the company's current EPS (TTM) is A-$4.64. In 2025 the company made an earnings per share (EPS) of A-$3.79 an increase over its 2024 EPS that were of A-$3.83.

EPS history for Bicara Therapeutics from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$4.5620.4%
2025A-$3.79-1.21%
2024A-$3.83